Viewing Study NCT00904150


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2025-12-29 @ 4:27 AM
Study NCT ID: NCT00904150
Status: COMPLETED
Last Update Posted: 2014-02-24
First Post: 2009-05-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of the Molecular Genetics of Menstrual Migraine
Sponsor: The City of London Migraine Clinic
Organization:

Study Overview

Official Title: A Case-control Study of the Molecular Genetics of Menstrual Migraine (Pure Menstrual and Menstrually-related Migraine)
Status: COMPLETED
Status Verified Date: 2014-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators hypothesize that genes that play a role in menstrual migraine can be identified using a well characterised migraine population and a comprehensive genome-wide association scan approach.

The aim of the study is to identify genes, genetic regions, and the effect of hormones on expression profiles in women with menstrual migraine compared to a control population with no personal or first-degree family history of migraine.

In this case control study, saliva samples will be taken from 300 cases and 300 controls for DNA analysis. Blood samples from 30 cases and 30 controls will be taken during the follicular phase as well as the luteal phase of the menstrual cycle for ribonucleic acid (RNA) analysis.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
REC Ref: 07/H0703/107 None None View
Proposal # 36470 None None View
Grant Application 2007/03 None None View